skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
New Oral Anticoagulants and the Cancer Patient
New Oral Anticoagulants and the Cancer Patient
Material Type:
Artigo 		Adicionar ao Meu Espaço

New Oral Anticoagulants and the Cancer Patient

Short, Nicholas J. ; Connors, Jean M.

The oncologist (Dayton, Ohio), 2014-01, Vol.19 (1), p.82-93 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
2
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
Material Type:
Artigo 		Adicionar ao Meu Espaço

How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

Short, Nicholas J ; Ravandi, Farhad

Haematologica (Roma), 2019-08, Vol.104 (8), p.1532-1541 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
3
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

Samra, Bachar ; Jabbour, Elias ; Ravandi, Farhad ; Kantarjian, Hagop ; Short, Nicholas J

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.70-70, Article 70 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
Material Type:
Artigo 		Adicionar ao Meu Espaço

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

Sasaki, Koji ; Ravandi, Farhad ; Kadia, Tapan M. ; DiNardo, Courtney D. ; Short, Nicholas J. ; Borthakur, Gautam ; Jabbour, Elias ; Kantarjian, Hagop M.

Cancer, 2021-06, Vol.127 (12), p.2049-2061 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017
Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute lymphoblastic leukemia: A population‐based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017

Sasaki, Koji ; Jabbour, Elias ; Short, Nicholas J. ; Jain, Nitin ; Ravandi, Farhad ; Pui, Ching‐Hon ; Kantarjian, Hagop

American journal of hematology, 2021-06, Vol.96 (6), p.650-658 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
6
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Abou Dalle, Iman ; Jabbour, Elias ; Short, Nicholas J. ; Ravandi, Farhad

Current treatment options in oncology, 2019-01, Vol.20 (1), p.4-13, Article 4 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
7
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN

Jabbour, Elias ; Short, Nicholas J. ; Montalban-Bravo, Guillermo ; Huang, Xuelin ; Bueso-Ramos, Carlos ; Qiao, Wei ; Yang, Hui ; Zhao, Chong ; Kadia, Tapan ; Borthakur, Gautam ; Pemmaraju, Naveen ; Sasaki, Koji ; Estrov, Zeev ; Cortes, Jorge ; Ravandi, Farhad ; Alvarado, Yesid ; Komrokji, Rami ; Sekeres, Mikkael A. ; Steensma, David P. ; DeZern, Amy ; Roboz, Gail ; Kantarjian, Hagop ; Garcia-Manero, Guillermo

Blood, 2017-09, Vol.130 (13), p.1514-1522 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Kadia, Tapan M ; Reville, Patrick K ; Wang, Xuemei ; Rausch, Caitlin R ; Borthakur, Gautam ; Pemmaraju, Naveen ; Daver, Naval G ; DiNardo, Courtney D ; Sasaki, Koji ; Issa, Ghayas C ; Ohanian, Maro ; Montalban-Bravo, Guillermo ; Short, Nicholas J ; Jain, Nitin ; Ferrajoli, Alessandra ; Bhalla, Kapil N ; Jabbour, Elias ; Takahashi, Koichi ; Malla, Rashmi ; Quagliato, Kelly ; Kanagal-Shamanna, Rashmi ; Popat, Uday R ; Andreeff, Michael ; Garcia-Manero, Guillermo ; Konopleva, Marina Y ; Ravandi, Farhad ; Kantarjian, Hagop M

Journal of clinical oncology, 2022-11, Vol.40 (33), p.3848-3857 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

Short, Nicholas J. ; Kantarjian, Hagop ; Ravandi, Farhad ; Daver, Naval

Therapeutic Advances in Hematology, 2019, Vol.10, p.2040620719827310-2040620719827310 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
10
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors

Short, Nicholas J ; Nguyen, Daniel ; Ravandi, Farhad

Blood cancer journal (New York), 2023-09, Vol.13 (1), p.142-142, Article 142 [Periódico revisado por pares]

London: Springer Nature B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (567)
  2. Anais de Congresso  (1)
  3. Resenhas  (1)
  4. Book Chapters  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (7)
  2. 1994Até2004  (9)
  3. 2005Até2010  (20)
  4. 2011Até2017  (89)
  5. Após 2017  (445)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.